FDA GMP Compliance Consultant: What Manufacturers Need to Know

If you're a manufacturer operating under FDA oversight — whether you're producing dietary supplements, pharmaceuticals, medical devices, or food products — the question of GMP compliance isn't really optional. It's the baseline. The real question is whether you're navigating it alone or with someone who has done it before.

This article covers what an FDA GMP compliance consultant actually does, what 21 CFR compliance looks like across different product categories, how to evaluate consultants when you're shopping, and what separates firms that consistently help clients pass audits from the ones that hand you a binder and disappear.

I've spent over eight years in this space and worked with more than 200 clients across manufacturing categories. In my view, most compliance failures I see aren't about ignorance of the regulations — they're about gaps between what a company thinks its systems are doing and what they're actually doing. That's the gap a good consultant closes.

What Does an FDA GMP Compliance Consultant Actually Do?

The short answer is that a GMP consultant helps you build, fix, or verify the systems that FDA expects to find when an investigator walks in the door. But that description undersells the work.

In practice, the job involves a few distinct activities:

Gap assessments. Before you can fix a compliance problem, you need to know where it is. A gap assessment compares your current operations against the applicable 21 CFR requirements and identifies where your documentation, processes, or training fall short. This is usually the starting point for any serious engagement.

SOP development and remediation. Standard operating procedures are the backbone of GMP compliance. If yours are missing, outdated, or written in a way that doesn't match what your team actually does, you have a documentation problem that will surface in any competent audit. A consultant either writes them for you or works with your team to bring existing documents into alignment.

Mock audits and pre-inspection readiness. One of the most valuable things a consultant can do is run a simulated FDA inspection before the real one. A well-run mock audit surfaces the same kinds of observations an FDA investigator would make — and gives you time to address them.

CAPA support. When you've already received a 483 observation or a warning letter, corrective and preventive action (CAPA) documentation becomes urgent. A consultant helps you build a response that's credible to FDA and actually addresses root cause, not just surface symptoms.

Training. Regulations change, personnel turn over, and procedural drift is constant. Ongoing training — particularly for production, quality, and management personnel — is a GMP requirement, not an elective.

21 CFR Compliance: Understanding the Regulatory Landscape

The "21 CFR" designation refers to Title 21 of the Code of Federal Regulations, which governs food and drugs in the United States. The specific part that applies to your operation depends on what you make.

Each of these frameworks shares a common logic — document what you do, do what you document, and demonstrate that your controls actually work — but the specific requirements vary considerably. A consultant who specializes in dietary supplement GMP (Part 111) doesn't automatically have deep expertise in pharmaceutical GMP (Part 211), and vice versa. When you're evaluating a firm, this distinction matters.

It's also worth noting that FDA's enforcement posture has become more aggressive in recent years. According to FDA's own data, the agency issued 44 warning letters related to drug GMP violations in fiscal year 2023, and dietary supplement enforcement actions have trended upward as FDA's Office of Dietary Supplement Programs has expanded its inspection capacity. The regulatory environment is not softening.

What FDA Investigators Actually Look For

Understanding how an FDA inspection works helps you understand what a GMP consultant should be preparing you for.

FDA investigators follow a structured inspection process. For most facilities, this involves a review of your quality system, a walkthrough of your manufacturing floor, a review of batch records and testing data, and interviews with personnel. The investigator is looking for evidence that your system works — not just evidence that you have documents.

The most common 21 CFR Part 111 observations I see involve inadequate component identity testing, incomplete batch production records, and CAPA systems that don't trace back to root cause. On the pharmaceutical side (Part 211), laboratory out-of-specification (OOS) handling and data integrity are consistently among the top cited deficiencies.

According to FDA's FY 2023 CDER inspection data, data integrity issues appeared in approximately 20% of all drug GMP-related warning letters — a figure that has remained stubbornly high despite years of industry guidance on the subject. That tells you this is a structural problem in how many companies operate, not an occasional slip.

A good mock audit surfaces these patterns before an investigator does. That's the practical value.

How to Choose an FDA GMP Compliance Consultant

The consulting market here is crowded, and the quality varies enormously. There are large firms with broad service catalogs — Eurofins Pharma Consulting and FDA Group are two names that appear frequently in industry searches — and there are smaller boutique practices that offer more direct access to senior expertise.

Neither model is automatically better. What you're evaluating is whether the consultant has specific, demonstrated experience with your product category and your regulatory framework, and whether they can show you a track record of clients who passed their audits.

Here are the questions I'd encourage any manufacturer to ask before hiring:

1. What specific 21 CFR parts do you work with most frequently? If a consultant hesitates here or gives you a vague answer about "all FDA-regulated products," that's a signal. Real expertise is usually narrower.

2. Can you share client outcomes — specifically audit results? A consultant who can't point to clients who passed FDA inspections or third-party audits after working with them is selling preparation without proof.

3. Who will actually be doing the work? Large firms sometimes use junior staff to execute engagements sold by senior partners. Know who you're getting.

4. What does your gap assessment process look like? This is the foundation of any GMP engagement. If the answer is vague, the work will probably be vague too.

5. How do you stay current on FDA guidance? FDA issues updated guidance documents, inspection trend data, and warning letters regularly. A consultant who doesn't actively follow these can't help you stay ahead of where enforcement is heading.

At Certify Consulting, we've maintained a 100% first-time audit pass rate across more than 200 clients. That's a number I take seriously, because it means every engagement has to end with a client who is genuinely ready — not just a client who has a compliance binder on a shelf.

The Most Common GMP Compliance Gaps (And How Consultants Fix Them)

In my experience, the compliance failures that lead to 483 observations and warning letters tend to cluster around a handful of recurring themes. Here's what I see most often and how a competent consultant addresses each one.

Inadequate Identity Testing for Components

Under 21 CFR Part 111 (dietary supplements), manufacturers are required to conduct at least one identity test on every incoming component. Many companies either skip this, rely solely on supplier certificates of analysis, or use testing methods that don't meet regulatory expectations. The fix involves establishing a compliant testing program — including validated methods — and building the documentation to show it.

Batch Record Deficiencies

A batch record is your evidence that a specific lot was manufactured in accordance with your master manufacturing record. Common problems include incomplete records, records that don't reflect what actually happened on the floor, and records that lack appropriate review signatures. A consultant audits your batch record format and traces a representative sample of historical records to identify gaps.

CAPA Systems That Don't Reach Root Cause

FDA expects your CAPA system to do more than document complaints. It should demonstrate that you investigated the root cause of a problem, took action to correct it, and verified that the action was effective. Systems that close CAPAs without genuine root cause analysis are a recurring inspection finding. The fix is usually a combination of SOP revision and training.

Data Integrity Issues

This is increasingly the issue that gets manufacturers into serious trouble. Under 21 CFR Part 211 and related frameworks, data must be attributable, legible, contemporaneously recorded, original, and accurate (the ALCOA principles). Common violations include backdated entries, overwritten records, and electronic data that lacks adequate audit trails. Addressing data integrity problems usually requires both procedural changes and, sometimes, system upgrades.

Training Documentation Gaps

GMP regulations require documented training for all personnel whose activities could affect product quality. Gaps in training records — particularly for production and quality personnel — are among the easiest observations for an investigator to make. A consultant establishes a compliant training matrix and ensures records are maintained properly.

What to Expect From a GMP Consulting Engagement

A typical GMP consulting engagement runs through several phases, though the specifics vary based on where you're starting.

Phase 1: Current State Assessment. This is the gap assessment — a systematic comparison of your operations against the applicable regulatory requirements. It produces a written finding report with prioritized recommendations.

Phase 2: Remediation. Based on the gap assessment findings, you and the consultant agree on a scope of work for remediation. This might include SOP development, batch record redesign, testing protocol validation, training program development, or CAPA system restructuring.

Phase 3: Verification. Before you face a real inspection, it makes sense to verify that your remediated system actually holds up. A mock audit — conducted by someone with real FDA inspection experience — is the best way to do this.

Phase 4: Ongoing Support. Compliance is not a one-time project. Regulations evolve, FDA priorities shift, and your business changes. Retainer-based ongoing support keeps your system current and gives you a resource when new questions arise.

Timelines vary. A straightforward dietary supplement manufacturer with one product line might move from gap assessment to mock audit in 60–90 days. A larger pharmaceutical operation with complex quality systems and multiple product lines might take six months or longer to work through a full remediation.

GMP Compliance for Dietary Supplement Manufacturers: A Specific Look

Because dietary supplement GMP (21 CFR Part 111) is one of the most common areas where manufacturers seek consulting help — and one of the areas where enforcement has accelerated — it's worth a closer look.

Part 111 became effective in 2010 for small manufacturers and has been fully in effect for all companies for over a decade. Despite that, FDA inspection data continues to show widespread noncompliance. In 2023, FDA's Office of Dietary Supplement Programs conducted hundreds of inspections and found that a significant majority of inspected facilities had at least one 483 observation.

The regulation covers the full manufacturing lifecycle: facility and equipment design, component receipt and testing, manufacturing operations, quality control, batch production records, laboratory operations, consumer complaints, and record retention. It is not a simple framework.

For supplement manufacturers, the single most important thing a GMP consultant does is establish a defensible component testing program. If you cannot demonstrate — through documented, validated testing — that your ingredients are what you say they are, everything else in your quality system is undermined. That's the foundation.

If you're looking for more detail on what a supplement-specific compliance program looks like, the GMP compliance guide for dietary supplement manufacturers at Certify Consulting walks through the Part 111 requirements systematically.

Red Flags When Evaluating GMP Consultants

A few things I'd watch for when you're evaluating options:

Guarantees without substance. Any consultant who guarantees you'll pass an FDA inspection without conducting a thorough assessment first is overselling. No one can guarantee an FDA outcome — what you can guarantee is thorough preparation.

Template-heavy, customization-light approaches. GMP compliance is not a fill-in-the-blank exercise. SOPs and batch records need to reflect your actual processes. A consultant who hands you generic templates without adapting them to your operation is not solving your compliance problem.

No direct experience with FDA investigators. There's a difference between someone who has studied FDA regulations and someone who has been through inspections — either as a former FDA investigator, as a quality professional at an inspected facility, or as a consultant who has supported clients through real inspections. That direct experience shapes how you prepare.

Unclear scope and deliverables. A GMP engagement should have a defined scope, clear deliverables, and a timeline you can hold the consultant to. Vague proposals that promise "comprehensive GMP support" without specifics make it hard to evaluate what you're actually buying.

Why First-Time Audit Pass Rates Matter

When I talk about our 100% first-time audit pass rate at Certify Consulting, I'm not leading with it as a marketing number. I'm leading with it because it captures something real about how this work should be done.

A first-time pass means the client didn't have to go back and remediate after an inspection. It means the gap assessment caught the real problems, the remediation actually fixed them, and the mock audit was rigorous enough to surface anything that remained. It means the client's team understood the system well enough to answer investigators' questions confidently.

That outcome requires thorough preparation, not just good paperwork. And it requires a consultant who is invested in the outcome, not just in delivering a report.

If you're preparing for an FDA inspection — or trying to get your quality system into shape before one happens — I'd encourage you to contact Certify Consulting to talk through where you are and what you need.

Last updated: 2026-04-29